4gl5
From Proteopedia
(Difference between revisions)
(4 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | {{STRUCTURE_4gl5| PDB=4gl5 | SCENE= }} | ||
- | ===Structure of human placental aromatase complexed with designed inhibitor HDDG029 (compound 4)=== | ||
- | {{ABSTRACT_PUBMED_22951074}} | ||
- | == | + | ==Structure of human placental aromatase complexed with designed inhibitor HDDG029 (compound 4)== |
- | [[http://www.uniprot.org/uniprot/CP19A_HUMAN CP19A_HUMAN | + | <StructureSection load='4gl5' size='340' side='right'caption='[[4gl5]], [[Resolution|resolution]] 3.48Å' scene=''> |
- | + | == Structural highlights == | |
- | ==Function== | + | <table><tr><td colspan='2'>[[4gl5]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4GL5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4GL5 FirstGlance]. <br> |
- | [ | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.48Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=G29:(6ALPHA,8ALPHA)-6-(BUT-2-YN-1-YLOXY)ANDROSTA-1,4-DIENE-3,17-DIONE'>G29</scene>, <scene name='pdbligand=HEM:PROTOPORPHYRIN+IX+CONTAINING+FE'>HEM</scene></td></tr> | |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4gl5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4gl5 OCA], [https://pdbe.org/4gl5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4gl5 RCSB], [https://www.ebi.ac.uk/pdbsum/4gl5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4gl5 ProSAT]</span></td></tr> | |
- | + | </table> | |
+ | == Disease == | ||
+ | [https://www.uniprot.org/uniprot/CP19A_HUMAN CP19A_HUMAN] Defects in CYP19A1 are a cause of aromatase excess syndrome (AEXS) [MIM:[https://omim.org/entry/139300 139300]; also known as familial gynecomastia. AEXS is characterized by an estrogen excess due to an increased aromatase activity. Defects in CYP19A1 are the cause of aromatase deficiency (AROD) [MIM:[https://omim.org/entry/613546 613546]. AROD is a rare disease in which fetal androgens are not converted into estrogens due to placental aromatase deficiency. Thus, pregnant women exhibit a hirsutism, which spontaneously resolves after post-partum. At birth, female babies present with pseudohermaphroditism due to virilization of extern genital organs. In adult females, manifestations include delay of puberty, breast hypoplasia and primary amenorrhoea with multicystic ovaries.<ref>PMID:8265607</ref> <ref>PMID:8530621</ref> <ref>PMID:9211678</ref> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/CP19A_HUMAN CP19A_HUMAN] Catalyzes the formation of aromatic C18 estrogens from C19 androgens. | ||
==See Also== | ==See Also== | ||
- | *[[Cytochrome P450|Cytochrome P450]] | + | *[[Cytochrome P450 3D structures|Cytochrome P450 3D structures]] |
- | + | == References == | |
- | == | + | <references/> |
- | <references | + | __TOC__ |
+ | </StructureSection> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: Ghosh | + | [[Category: Ghosh D]] |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Current revision
Structure of human placental aromatase complexed with designed inhibitor HDDG029 (compound 4)
|